From October 24 to 26, a delegation of fourteen professors, lecturers and researchers from the Faculty of Health, led by Dean Matthieu Resche-Rigon and the co-director of the Institute of Women’s Health, Vassilis Tsatsaris, visited Singapore for the Women’s Health Conference 2024. A rich moment of scientific exchange, and a new stage in the partnership between Université Paris Cité and the National University of Singapore.
Speakers at the Women’s Health Conference 2024, in Singapore on October 26, 2024, at the closing ceremony.
© Crédit photo : National University of Singapore
Université Paris Cité and the National University of Singapore: a long-standing partnership
The National University of Singapore (NUS) has been cooperating closely with the Sorbonne Paris Cité (USPC) alliance for over ten years. In 2020, the newly-created Université Paris Cité signed three partnership agreements with NUS, making this cooperation a privileged partnership. These agreements, which cover research and training, establish close collaboration between the Faculty of Health and the Yong Loo Lin School of Medicine at NUS.
In 2023, under the impetus of Mariana Losada, head of university cooperation for Southeast Asia at UPCité, Sciences Po and Inalco, and the Faculty of Health, Université Paris Cité and the National University of Singapore launched a new area of cooperation in the field of women’s health. A first joint conference was organized in Djerba, on the theme of prevention and early detection of non-communicable diseases. Last month’s Women’s Health Conference was held within the framework of this new partnership.
A large delegation and high-level presentations
This was an important event. In addition to Dean Matthieu Resche-Rigon and Prof. Vassilis Tsatsaris, co-director of the Women’s Health Institute at Université Paris Cité, eleven of the university’s professors, lecturers and researchers made the trip: Julia Antero, Prof. Elie Azria, Prof. Anne Chantry, Prof. Charles Chapron, Julie Gaillard, Prof. Édouard Lecarpentier, Prof. Gabriel Livera, Prof. Alexandre Mebazaa, International Vice-Dean of the Faculty, Prof. Pietro Santulli, Yves Ville and Wen Lun Yuan. They were welcomed on site by Mariana Losada, one of the initiators of this project at Université Paris Cité, who also spoke at the conference.
The conferences provided a comprehensive overview of women’s health in 2024. Financing women’s health, social and environmental inequalities, age, innovative technologies, sports practice, maternity, reproduction and fertility, as well as targeted pathologies, were all addressed. The emphasis this year was on food, a theme that ran through the conference. In addition to researchers from Université Paris Cité and NUS, there were talks by scientists from Harvard in the USA, Tunisia, China and India.
Strong orientations for global and preventive women’s health
The Women’s Health Conference 2024 is not just a meeting of experts and specialists on specific topics. On the contrary, Université Paris Cité and the National University of Singapore intend to convey messages that are of interest to society as a whole, and to show that women’s health throughout their lives is the concern of the entire population. In the future, the ability to offer genuine prevention in women’s health will be crucial, for women of course, but above all for all populations.
À lire aussi
La FDA américaine valide iBox, algorythme français de prédiction de la survie des greffons rénaux
La semaine dernière, l’administration américaine de régulation des médicaments (Food and Drug Administration, FDA) a donné un avis favorable à la qualification du système algorithmique iBox, développé par l'équipe du Paris Transplant Group (Université...
The US FDA Approves iBox, French Algorithm for Predicting Kidney Graft Survival
Last week, the American Food and Drug Administration (FDA) gave a favorable opinion on the qualification of the iBox algorithmic system, developed by the Paris Transplant Group team (Université Paris Cité, Inserm, AP -HP) led by Professor Alexandre Loupy....